For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune...
Vous n'êtes pas connecté
Maroc - ONCOLOGYNEWS.COM.AU - A La Une - 17/08/2024 14:16
Chimeric antigen receptor (CAR) T–cell immunotherapy re-engineers a patient’s immune cells to target cancer cells. While successful in some types of leukaemia, the approach has yet to realise its potential against paediatric solid tumours. Scientists at St. Jude Children’s Research Hospital have identified a way to improve CAR T–cell homing – a T cell’s ability [...]
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune...
UF Health Cancer Institute researchers have discovered a small compound produced naturally by gut bacteria that doubled the response to lung cancer...
Oscar Murphy has an aggressive form of the blood cancer and is the first to get CAR-T therapy in the UK.
A group of cytotoxic T cells surrounding a cancer cell. Credit: NIH / Flickr / Public domain Human immune systems do not function in the same way...
A group of cytotoxic T cells surrounding a cancer cell. Credit: NIH / Flickr / Public domain Human immune systems do not function in the same way...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a...
Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer cells. The Saudi Food and...
Researchers at the University of Southampton, UK, have developed a promising new way to bolster the body’s immune system response to cancer. In a...
Researchers at the University of Southampton, UK, have developed a promising new way to bolster the body’s immune system response to cancer. In a...